Results 331 to 340 of about 3,160,474 (348)
Some of the next articles are maybe not open access.
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Nature Reviews Clinical Oncology, 2021Mary Beth Beasley +2 more
exaly
Treatment of renal cell carcinoma: Current status and future directions
Ca-A Cancer Journal for Clinicians, 2017Pedro Coelho Barata, Brian I Rini
exaly
The role of the microbiome in cancer development and therapy
Ca-A Cancer Journal for Clinicians, 2017Aadra P Bhatt, Matthew R Redinbo
exaly
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
Ca-A Cancer Journal for Clinicians, 2017Fernanda G Herrera +2 more
exaly
Immunotherapy of cancer in 2012
Ca-A Cancer Journal for Clinicians, 2012Lisa H Butterfield, Ahmad A Tarhini
exaly
Immunity, Components of the Immune System and Immune Response
Biologicals, 1997openaire +2 more sources
Blueprint for cancer research: Critical gaps and opportunities
Ca-A Cancer Journal for Clinicians, 2021exaly
Recent Progress in the Management of Advanced Renal Cell Carcinoma
Ca-A Cancer Journal for Clinicians, 2007Brian I Rini
exaly
METHYLPHENIDATE AND THE IMMUNE SYSTEM
Journal of the American Academy of Child & Adolescent Psychiatry, 1997D L, Auci, S, Fikrig, J, Rodriquez
openaire +2 more sources
Immune defence – the immune system immune defence immune system blood immune system
openaire +1 more source